Antiviral prophylaxis vs placebo or no treatment
Death associated with CMV disease · solid organ transplant recipients
Antiviral prophylaxis probably leads to lower death due to CMV disease compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
- Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients 2024 · Cochrane Headline outcomes onlyRR 0.26 [0.08, 0.78]7 studies · 1300 participantsModerate